Stifel Maintains Buy on Boston Scientific, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a Buy rating on Boston Scientific and raises the price target from $85 to $100.
October 18, 2024 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Rick Wise has reiterated a Buy rating for Boston Scientific and increased the price target from $85 to $100, indicating a positive outlook.
The increase in the price target from $85 to $100 by Stifel suggests a strong positive outlook for Boston Scientific. This is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100